Monday 29 April 2019

Early Hemophilia A Study Finds Gene Therapy Produces FVIIa Levels Needed to Control Bleeding - Hemophilia News Today

Early Hemophilia A Study Finds Gene Therapy Produces FVIIa Levels Needed to Control Bleeding  Hemophilia News Today

A gene therapy-based factor VIIa (FVIIa) used as prophylactic lessened bleeding episodes in a rat model and may work regardless of inhibitors, a study says.

No comments:

Post a Comment